Alzheimer's Drug Discovery Foundation
Alzheimer's Drug Discovery Foundation reported $82.2 million in revenue and $47.6 million in expenses for calendar year 2025. Of every $100 it spent, $83.98 went to program services, $6.38 to management and general costs and $9.64 to fundraising. Its largest source of revenue was contributions and grants: 81.5% of the total. The highest compensation it reported for one person was $1,186,018 (FOUNDING ED & CSO). 22 people received more than $100,000 in reportable compensation. Revenue rose 262% between 2019 and 2025. Source: Form 990, 2025.
Where $100 of spending went
Calendar year 2025 · Form 990, Part IX, line 25 · total expenses $48MFor context, the median across 54 covered social science charities: $84.80 programs, $13.80 management, $1.40 fundraising (medians computed separately, so they may not sum to $100).
Where $100 of revenue came from
Calendar year 2025 · Form 990, Part VIII · total revenue $82M- Contributions & grants (non-government)$80.90 $67M
- Program service revenue$14.08 $12M
- Investment income$5.02 $4.2M
Other revenue was negative: −$599K. The bar shows the positive sources only.
The 990 scorecard · same measures for every charity, no grades
| Measure | 2025 | Median |
|---|---|---|
| Program services Part IX 25(B) ÷ 25(A) | 84.0% | 81.3% |
| Management & general Part IX 25(C) ÷ 25(A) | 6.4% | 13.2% |
| Fundraising Part IX 25(D) ÷ 25(A) | 9.6% | 1.3% |
| Fundraising cost per $1 of contributions Part IX 25(D) ÷ Part VIII 1h | $0.07 | $0.03 |
| Contributions & grants share of revenue Part VIII 1h ÷ 12 | 81.5% | 81.3% |
| Government grants share of revenue Part VIII 1e ÷ 12 | 0.0% | 1.1% |
| Program service revenue share Part VIII 2g ÷ 12 | 14.2% | 4.4% |
| Highest reported compensation Part VII-A, columns D–F | $1,186,018 | $467,896 |
| Highest compensation as share of expenses Part VII-A ÷ Part IX 25(A) | 2.49% | 2.13% |
| People paid over $100,000 Part VII, line 2 | 22 | 19 |
| Net assets, in months of expenses Part X 33(B) ÷ monthly expenses | 63.6 | 16.5 |
| Independent voting board members Part VI 1a–1b | 32 of 33 | 96.5% |
A median is context, not a target: hospitals, universities, food banks and grantmakers spend in very different ways. What these measures can and can't tell you.
What the money paid for, in its own words
2025 · Form 990, Part III · the three largest programs by expenseThe alzheimer's Drug Discovery Foundation is dedicated to rapidly accelerating the discovery of drugs to prevent, treat and cure alzheimer's disease and related dementias. The addf is solely focused on funding the development of drugs for alzheimer's, employing a venture philanthropy model to support research in academia and the biotech industry
Highest reported compensation
2025 · Form 990, Part VII, Section A · roles as filed; names are in the filing, not here| Role | From this org | From related orgs | Other | Total |
|---|---|---|---|---|
| FOUNDING ED & CSO Director/trustee, officer, 40.00 hrs/week | $691,744 | $0 | $494,274 | $1,186,018 |
| CEO Officer, 40.00 hrs/week | $682,100 | $0 | $58,069 | $740,169 |
| EXEC. DIR., DRUG DEV. Highest compensated employee, 40.00 hrs/week | $496,050 | $0 | $53,715 | $549,765 |
| CFO & HEAD OF MISSION-REL. INVESTING Officer, 40.00 hrs/week | $384,929 | $0 | $41,275 | $426,204 |
| CHIEF EXT. AFFAIRS & PHILANTHROPY OFFICER Highest compensated employee, 40.00 hrs/week | $394,697 | $0 | $27,629 | $422,326 |
| HEAD OF SEARCH & EVAL. Highest compensated employee, 40.00 hrs/week | $359,652 | $0 | $61,170 | $420,822 |
| SENIOR DIRECTOR DXA Highest compensated employee, 40.00 hrs/week | $330,179 | $0 | $39,967 | $370,146 |
| ATTY., MISSION-REL. INVEST. Highest compensated employee, 40.00 hrs/week | $218,807 | $0 | $53,924 | $272,731 |
22 people received more than $100,000 in reportable compensation from Alzheimer's Drug Discovery Foundation (Part VII, line 2). Compensation of current officers, directors and key employees totaled $2.4M (Part IX, line 5).
7 years of filings
Form 990, Parts I, VII, IX and X · each row is that year's own filing, linkedGovernance answers, as filed
2025 · the organization's own yes/no answers; explanations, if any, are in Schedule O of the filing · what each means- Voting board members, and how many are independent Part VI, lines 1a–1b33 · 32 independent
- Audited financial statements Part XII 2bYes
- Conflict-of-interest policy Part VI 12aYes
- Whistleblower policy Part VI 13Yes
- Document retention policy Part VI 14Yes
- Independent process for top executive pay Part VI 15aYes
- Board given the 990 before filing Part VI 11aYes
- Family or business ties among insiders Part VI 2Yes
- Aware of a significant diversion of assets Part VI 5No
- Excess benefit transaction with an insider Part IV 25aNo
- Loans to or from insiders outstanding Part IV 26No
- Lobbying, or a 501(h) election in effect Part IV 4No
- Over $15,000 of professional fundraising services Part IV 18No
- Over $10,000 of activity outside the U.S. Part IV 14bYes
- Employees Part I, line 537
- Volunteers Part I, line 632
Largest outside contractors
2025 · Form 990, Part VII, Section B · businesses only| VITAL IMPACT LLC Consulting services | $723,643 |
| BEACON HILL SOLUTIONS GROUP LLC Staffing services | $193,585 |
| LAMPROS KOURTIS Consulting services | $172,813 |
| PBFERRELL LLC Consulting services | $164,400 |
Individuals listed as contractors are left out. 13 contractors were paid more than $100,000 in all.
Private foundation grants it received
92 private foundations reported grants to Alzheimer's Drug Discovery Foundation totaling $3.3M on their tax year 2023 Form 990-PF returns. See which foundations, on WHOFUNDS.
Source: WHOFUNDS open grant graph, matched from Form 990-PF Part XV.
Correct a figure or respond
Every number above is copied from Alzheimer's Drug Discovery Foundation's own Form 990. If one doesn't match the filing, that's our error and we'll fix it. If you work for Alzheimer's Drug Discovery Foundation, you can publish a response that is linked from this page.
Share or embed this breakdown
Of every $100 Alzheimer's Drug Discovery Foundation spent in 2025, $83.98 went to programs. The full breakdown, from its IRS Form 990:
Embed on your site
Similar-sized charities in this cause
- American Enterprise Institute for Public Policy ResearchWashington, DC · revenue $75M · programs 78.5% · FY2025
- The Brookings InstitutionWashington, DC · revenue $116M · programs 83.0% · FY2025
- Human Resources Research OrganizationAlexandria, VA · revenue $70M · programs 81.3% · FY2025
- Ithaka HarborsNew York, NY · revenue $126M · programs 91.4% · 2024
- Buck Institute for Research on AgingNovato, CA · revenue $57M · programs 75.1% · FY2025
All social science charities · Largest charities in New York
Questions people ask
How much of Alzheimer's Drug Discovery Foundation's spending goes to programs?
In calendar year 2025, Alzheimer's Drug Discovery Foundation reported that 84.0% of its $47.6 million in expenses went to program services, 6.4% to management and general and 9.6% to fundraising (Form 990, Part IX).
How much does Alzheimer's Drug Discovery Foundation pay its top executive?
The largest total compensation Alzheimer's Drug Discovery Foundation reported for one person in calendar year 2025 was $1,186,018, for the role of FOUNDING ED & CSO (Form 990, Part VII, including compensation from related organizations and other compensation).
Where does Alzheimer's Drug Discovery Foundation get its money?
Of $82.2 million in revenue in calendar year 2025, 81.5% came from contributions and grants and 14.2% from program service revenue (Form 990, Part VIII).
Is Alzheimer's Drug Discovery Foundation a registered charity?
The IRS lists EIN 20-1082179 as a 501(c)(3) organization (publicly supported organization (170(b)(1)(a)(vi))), and its records show contributions as tax-deductible. Form 990 filings on record here cover tax years 2019, 2020, 2021, 2022, 2023, 2024, 2025. A filing shows what the organization reported; it doesn't by itself show whether a program works.
Sources
- 2025: Form 990 for calendar year 2025, object 202602619349300605 · read the filing
- 2024: Form 990 for calendar year 2024 (amended), object 202632619349300028 · read the filing
- 2023: Form 990 for calendar year 2023 (amended), object 202612649349301106 · read the filing
- 2022: Form 990 for calendar year 2022, object 202343199349327799 · read the filing
- 2021: Form 990 for calendar year 2021, object 202243199349323979 · read the filing
- 2020: Form 990 for calendar year 2020, object 202200149349300710 · read the filing
- 2019: Form 990 for calendar year 2019, object 202023219349304682 · read the filing
All filings for EIN 20-1082179: ProPublica Nonprofit Explorer · IRS Tax Exempt Organization Search. Figures are as the organization reported them; we have not audited them.